135 related articles for article (PubMed ID: 11068424)
1. [Depression during interferon therapy in renal cell cancer patients--comparison with chronic hepatitis C patients].
Sakamoto H; Inoue K; Shimada M; Yoshida H; Otsubo T; Miyaoka H; Kamizima K; Ishii M; Mitamura K
Nihon Hinyokika Gakkai Zasshi; 2000 Sep; 91(9):611-7. PubMed ID: 11068424
[TBL] [Abstract][Full Text] [Related]
2. [Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
Otsubo T; Miyaoka H; Kamijima K; Onuki M; Ishii M; Mitamura K
Seishin Shinkeigaku Zasshi; 1997; 99(3):101-27. PubMed ID: 9136611
[TBL] [Abstract][Full Text] [Related]
3. Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
Małyszczak K; Inglot M; Frydecka D; Hadryś T; Pawłowski T
Adv Clin Exp Med; 2019 Sep; 28(9):1217-1222. PubMed ID: 30811903
[TBL] [Abstract][Full Text] [Related]
4. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
Capuron L; Ravaud A; Miller AH; Dantzer R
Brain Behav Immun; 2004 May; 18(3):205-13. PubMed ID: 15050647
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
Neri S; Pulvirenti D; Bertino G
Clin Drug Investig; 2006; 26(11):655-62. PubMed ID: 17163300
[TBL] [Abstract][Full Text] [Related]
6. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
7. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated.
Bannink M; Kruit WH; Van Gool AR; Sleijfer S; van der Holt B; Eggermont AM; Stoter G; Hengeveld MW
Psychosomatics; 2008; 49(1):56-63. PubMed ID: 18212177
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
[TBL] [Abstract][Full Text] [Related]
10. DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN.
Vabo IL; Ferreira LE; Pace FH
Arq Gastroenterol; 2016; 53(1):20-4. PubMed ID: 27281500
[TBL] [Abstract][Full Text] [Related]
11. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
Schaefer M; Schwaiger M; Garkisch AS; Pich M; Hinzpeter A; Uebelhack R; Heinz A; van Boemmel F; Berg T
J Hepatol; 2005 Jun; 42(6):793-8. PubMed ID: 15885349
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C.
Huckans M; Fuller B; Wheaton V; Jaehnert S; Ellis C; Kolessar M; Kriz D; Anderson JR; Berggren K; Olavarria H; Sasaki AW; Chang M; Flora KD; Loftis JM
J Psychosom Res; 2015 Feb; 78(2):184-92. PubMed ID: 25219976
[TBL] [Abstract][Full Text] [Related]
13. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
[TBL] [Abstract][Full Text] [Related]
14. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
Maes M; Bonaccorso S; Marino V; Puzella A; Pasquini M; Biondi M; Artini M; Almerighi C; Meltzer H
Mol Psychiatry; 2001 Jul; 6(4):475-80. PubMed ID: 11443537
[TBL] [Abstract][Full Text] [Related]
15. Quinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis.
Baranyi A; Meinitzer A; Breitenecker RJ; Amouzadeh-Ghadikolai O; Stauber R; Rothenhäusler HB
PLoS One; 2015; 10(9):e0137022. PubMed ID: 26368809
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C.
Malaguarnera M; Laurino A; Di Fazio I; Pistone G; Castorina M; Guccione N; Rampello L
J Interferon Cytokine Res; 2001 May; 21(5):273-8. PubMed ID: 11429157
[TBL] [Abstract][Full Text] [Related]
17. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms.
Constant A; Castera L; Dantzer R; Couzigou P; de Ledinghen V; Demotes-Mainard J; Henry C
J Clin Psychiatry; 2005 Aug; 66(8):1050-7. PubMed ID: 16086622
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
Baranyi A; Meinitzer A; Putz-Bankuti C; Stauber R; Kapfhammer HP; Rothenhäusler HB
Psychosom Med; 2014 Apr; 76(3):197-207. PubMed ID: 24608038
[TBL] [Abstract][Full Text] [Related]
19. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.
Bonaccorso S; Puzella A; Marino V; Pasquini M; Biondi M; Artini M; Almerighi C; Levrero M; Egyed B; Bosmans E; Meltzer HY; Maes M
Psychiatry Res; 2001 Dec; 105(1-2):45-55. PubMed ID: 11740974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
